BI X

BI X is the digital innovation lab and wholly owned subsidiary of Boehringer Ingelheim focused on identifying, testing, and validating digital solutions across the pharmaceutical value chain. The company works on software, digital products, and healthcare-related IT solutions intended to support scientific research, operational excellence, and patient impact in human and animal health. BI X has emphasized external co-creation and partnership models with startups, research groups, and scale-ups, including work in digital healthcare, neurological rehabilitation, and single-cell multimodal omics–related applications. Rather than operating as a traditional therapeutics developer, BI X functions as a health-focused digital platform and product development organization embedded within a major pharmaceutical group.